Compare NTRB & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTRB | RDZN |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.7M | 75.2M |
| IPO Year | N/A | N/A |
| Metric | NTRB | RDZN |
|---|---|---|
| Price | $4.62 | $1.65 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | 21.2K | ★ 250.2K |
| Earning Date | 12-03-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,578,059.00 | ★ $48,035,296.00 |
| Revenue This Year | $560.75 | $38.45 |
| Revenue Next Year | $588.39 | $66.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.92 | 3.42 |
| 52 Week Low | $3.72 | $0.68 |
| 52 Week High | $11.78 | $2.99 |
| Indicator | NTRB | RDZN |
|---|---|---|
| Relative Strength Index (RSI) | 28.31 | 60.85 |
| Support Level | $4.59 | $1.25 |
| Resistance Level | $4.99 | $1.44 |
| Average True Range (ATR) | 0.30 | 0.15 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 0.83 | 81.00 |
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.